McClung David
- SEC CIK
- 0001686155
No open-market purchases or sales filed in the past year.
Current role at each company
- BCDA BioCardia, Inc.Chief Financial Officeras of Jul 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McClung David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 (view filing) | Jun 30 | 2 days | McClung DavidChief Financial Officer | PPurchase | +4.82K | $2.08 | +$10.0K | +11.2%48.0K after | |
| Jul 2, 2025 (view filing) | Jun 30 | 2 days | McClung DavidChief Financial Officer | PPurchase | +4.82K | – | – | –26.3K after | Derivative |
| Apr 25, 2025 (view filing) | Apr 23 | 2 days | McClung DavidChief Financial Officer | PPurchase | +13.1K | $1.91 | +$25.1K | +43.7%43.1K after | |
| Apr 25, 2025 (view filing) | Apr 23 | 2 days | McClung DavidChief Financial Officer | PPurchase | +13.1K | – | – | –21.5K after | Derivative |
| Oct 11, 2022 (view filing) | Oct 10 | 1 day | McClung DavidChief Financial Officer | PPurchase | +2.00K | $2.07 | +$4.14K | +2.6%78.5K after |